Castle Biosciences’ (CSTL) Overweight Rating Reaffirmed at Stephens
Stephens reissued their overweight rating on shares of Castle Biosciences (NASDAQ:CSTL – Free Report) in a report issued on Thursday morning,Benzinga reports. They currently have a $41.00 target price on the stock. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group raised their price objective on shares of Castle Biosciences […]
More Stories
90,031 Shares in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Purchased by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during...
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in Carter’s, Inc. (NYSE:CRI)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Carter’s, Inc....
Universal Beteiligungs und Servicegesellschaft mbH Buys New Stake in Turning Point Brands, Inc. (NYSE:TPB)
Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Turning Point Brands, Inc. (NYSE:TPB – Free Report) during the...
Universal Beteiligungs und Servicegesellschaft mbH Invests $2.36 Million in New Mountain Finance Co. (NASDAQ:NMFC)
Universal Beteiligungs und Servicegesellschaft mbH bought a new position in New Mountain Finance Co. (NASDAQ:NMFC – Free Report) during the...
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 30,607 Shares of NMI Holdings, Inc. (NASDAQ:NMIH)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of NMI Holdings,...
Mackenzie Financial Corp Makes New $609,000 Investment in MSC Industrial Direct Co., Inc. (NYSE:MSM)
Mackenzie Financial Corp acquired a new position in shares of MSC Industrial Direct Co., Inc. (NYSE:MSM – Free Report) in...